Stay updated on SHP2 Inhibitor BBP-398 Clinical Trial

Sign up to get notified when there's something new on the SHP2 Inhibitor BBP-398 Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SHP2 Inhibitor BBP-398 Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    Revision updated to v3.5.0, replacing the previous v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-18T15:40:55.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-11T14:08:39.000Z thumbnail image
  4. Check
    26 days ago
    No Change Detected
  5. Check
    47 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2. The old 3.4.1 notice and the government funding lapse notice have been removed.
    Difference
    0.5%
    Check dated 2026-02-11T04:23:00.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    Added a site-wide notice about government funding lapse and NIH operations; updated revision from v3.4.0 to v3.4.1.
    Difference
    0.5%
    Check dated 2026-02-04T04:04:23.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    The page now includes a new 'Show glossary' option and a 'Revision: v3.4.0' note. Existing metadata labels were slightly adjusted (for example, 'Last Update Submitted that Met QC Criteria' capitalization changes and 'No FEAR Act Data' replacing the earlier 'No FEAR Act data').
    Difference
    0.2%
    Check dated 2026-01-28T00:39:09.000Z thumbnail image
  8. Check
    75 days ago
    Change Detected
    Summary
    Revision: v3.3.4 replacing the previous v3.3.3 on the page.
    Difference
    0.1%
    Check dated 2026-01-14T00:48:51.000Z thumbnail image

Stay in the know with updates to SHP2 Inhibitor BBP-398 Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SHP2 Inhibitor BBP-398 Clinical Trial page.